XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.3
License Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
License revenue $ 1,000 $ 0 $ 1,000 $ 3,600
Lexeo Therapeutics, Inc        
Disaggregation of Revenue [Line Items]        
License revenue     0 $ 3,500
Ray Therapeutics, Inc        
Disaggregation of Revenue [Line Items]        
License revenue 1,000   1,000  
Receivable for license revenue related to the first development milestone $ 1,000   $ 1,000